Novel potential mechanisms of acquired resistance to anti-EGFR monoclonal antibody (mAb) therapy detected in liquid biopsies (LBx) from patients (pts) with advanced colorectal cancer (CRC).

Autor: Parseghian, Christine Megerdichian, Lee, Jessica Kim, Quintanilha, Julia, Schrock, Alexa B., Graf, Ryon, Pasquina, Lincoln, Sivakumar, Smruthy, Oxnard, Geoffrey R., Tukachinsky, Hanna, Klempner, Samuel J., Kopetz, Scott
Zdroj: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p199-199, 235p
Databáze: Supplemental Index